TIME AND DOSE-RELATED EFFECTS ON THE LIPID PROFILE IN HYPERLIPIDEMIA PATIENTS FOLLOWING TRIPLE COMBINATION THERAPY WITH EZETIMIBE/SIMVASTATIN plus NIACIN

被引：0
|
作者：
Brown, B. G. [1 ]
Fazio, S. [2 ]
Guyton, J. R. [3 ]
Polis, A. [4 ]
Tomassini, J. E. [4 ]
Tershakovec, A. M. [4 ]
机构：
[1] Univ Washington, Div Cardiol, Seattle, WA 98195 USA
[2] Vanderbilt Univ, Med Ctr, Vanderbilt Lipid Lab, Nashville, TN USA
[3] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
[4] Merck & Co Inc, N Wales, PA USA
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2008年 / 9卷 / 01期
关键词：
D O I：
10.1016/S1567-5688(08)70749-9
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：186 / 187
页数：2
相关论文
共 50 条
  • [1] SAFETY AND TOLERABILITY OF THE TRIPLE COMBINATION EZETIMIBE/SIMVASTATIN plus EXTENDED RELEASE NIACIN IN HYPERLIPIDEMIA PATIENTS
    Guyton, J. R.
    Brown, B. G.
    Fazio, S.
    Polis, A.
    Tomassini, J. E.
    Tershakovec, A. M.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 261 - 261
  • [2] Safety and tolerability of the triple combination ezetimibe/simvastatin plus extended release niacin in Hyperlipidemia patients
    Guyton, John R.
    Brown, B. Greg
    Fazio, Sergio
    Polis, Adam
    Tomassini, Joanne E.
    Tershakovec, Andrew M.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : A329 - A329
  • [3] Long-Term Safety and Efficacy of Triple Combination Ezetimibe/Simvastatin Plus Extended-Release Niacin in Patients With Hyperlipidemia
    Fazio, Sergio
    Guyton, John R.
    Polis, Adam B.
    Adewale, Adeniyi J.
    Tomassini, Joanne E.
    Ryan, Nicholas W.
    Tershakovec, Andrew M.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2010, 105 (04): : 487 - 494
  • [4] Triple combination Ezetimibe/Simvastatin plus extended release Niacin therapy improves ratios of ApoB/ApoA-I containing lipoproteins in hyperlipidemia patients
    Fazio, S.
    Brown, B. G.
    Guyton, J. R.
    Polis, A.
    Tomassini, J.
    Tershakovec, A. M.
    [J]. EUROPEAN HEART JOURNAL, 2008, 29 : 345 - 346
  • [5] Effects of atorvastatin, rosuvastatin, atorvastatin plus ezetimibe, and rosuvastatin plus ezetimibe on lipid profile in patients with hyperlipidemia
    Serkan, Cay
    Funda, Tuna
    Burcu, Demirkan
    Mucahit, Yetim
    Zafer, Buyuktierzi
    Erkan, Baysal
    Sule, Korkmaz
    [J]. CARDIOVASCULAR DRUGS AND THERAPY, 2007, 21 : S73 - S73
  • [6] A REAL WORLD COMPARISON OF COMBINED LIPID TARGET ATTAINMENT BETWEEN COMBINATION NIACIN EXTENDED-RELEASE plus ANY STATIN THERAPY AND FIXED DOSE SIMVASTATIN plus EZETIMIBE
    Simko, R. J.
    Quimbo, R. A.
    Cziraky, M. J.
    Balu, S.
    [J]. VALUE IN HEALTH, 2008, 11 (06) : A382 - A382
  • [7] Hypolipidemic and pleiotropic effects of a combination of simvastatin and ezetimibe in patients with different types of hyperlipidemia
    Sumarokov, A. B.
    Kukharchuk, V. V.
    [J]. TERAPEVTICHESKII ARKHIV, 2014, 86 (12): : 107 - 115
  • [8] Reduction in cardiovascular events and associated cost after treatment initiation with niacin extended-release plus simvastatin combination therapy versus simvastatin plus ezetimibe fixed dose therapy
    Simko, R.
    Quimbo, R.
    Cziraky, M. J.
    Balu, S.
    [J]. EUROPEAN HEART JOURNAL, 2009, 30 : 368 - 368
  • [9] High-Dose Simvastatin Exhibits Enhanced Lipid-Lowering Effects Relative to Simvastatin/Ezetimibe Combination Therapy
    Snowden, Stuart G.
    Grapov, Dmitry
    Settergren, Magnus
    D'Alexandri, Fabio Luiz
    Haeggstrom, Jesper Z.
    Fiehn, Oliver
    Hyotylainen, Tuulia
    Pedersen, Theresa L.
    Newman, John W.
    Oresic, Matej
    Pernow, John
    Wheelock, Craig E.
    [J]. CIRCULATION-CARDIOVASCULAR GENETICS, 2014, 7 (06) : 955 - 964
  • [10] LONG-TERM EFFECT OF COMBINATION EZETIMIBE/SIMVASTATIN plus EXTENDED-RELEASE NIACIN (E/S plus N) ON LIPOPROTEIN SUBCLASSES IN PATIENTS WITH HYPERLIPIDEMIA (HL)
    Fazio, S.
    Guyton, J.
    Polis, A.
    Adewale, A.
    Tomassini, J.
    Tershakovec, A.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
12345